All news


PhD students, come and take part to the Bio Business Week !

BioBusiness Week 2015

After a successful first edition in 2014 … Save the Date ! The second edition will take place in Angers (France). Attend to a fast track training to create your start up, coached by professionals. Come with your scientific work, leave with a business plan.


The excellence of CESTI IHU was recognized by a scientific committee of international experts

The CESTI IHU International Scientific Council or Scientific Adisory Board (SAB) met for the first time on 19 and 20 February 2015. Bringing together eminent world-renowned scientists, its role is to assess the quality of the teams' work and to validate the IHU's strategy.


Valneva Announces Approval of an EB66®-based Prototype Influenza Vaccine in Japan


[Press release] Valneva announced today that the Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has received manufacturing and marketing approval for a cell culture pandemic influenza vaccine (prototype) (General name: Emulsion Cell Culture Influenza HA Vaccine (Prototype)). This is a result of a co-development between GlaxoSmithKline and Kaketsuken.


Valneva announces signing of an exclusive license agreement in China


[Press release] Valneva, a leading pure play vaccines biotech company, announced today that it has signed a n exclusive license agreement with the Chinese company Jianshun Biosciences Ltd to commercialize Valneva’s EB66® cell line for the manufacturing of human and veterinary vaccines in People’s Republic of China only.